Press Releases Voyageur Pharmaceuticals Ltd.

Equities

VM

CA92918C1014

Delayed Toronto S.E. Other stock markets 11:49:35 17/06/2024 pm IST			5-day change	1st Jan Change
0.075 ^CAD	-6.25%		-6.25%	0.00%

11/06	Voyageur Pharmaceuticals Ltd. and Rain Cage Carbon Inc. Announce Follow Up on the First Commercial Creation of V@C60 Endohedral Fullerene	CI
28/05	Voyageur Pharmaceuticals Ltd Secures USD 1.9 Million Sales Contract for SmoothXTM 2% Barium Contrast	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Voyageur Pharmaceuticals and Rain Cage Carbon Partner to Develop Advanced Radiology Contrast Agents	11/06	AQ
Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development	11/06	AQ
Voyageur Pharmaceuticals Secures $1.9 Million Sales Contract for Latin America	28/05	AQ
Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium Contrast	28/05	AQ
Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors	03/04	AQ
Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options	27/03	AQ
Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development	13/03	AQ
Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement	04/03	AQ
Voyageur Pharmaceuticals Ltd. Announces Closing of Private Placement	01/03	AQ
Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors	22/12	AQ
Voyageur Pharmaceuticals Ltd and Rain Cage Carbon Inc, Announce Breakthrough in Imaging Technology with Vanadium Fullerene Molecule	21/12	AQ
Voyageur Pharmaceuticals takes major step forward announcing international expansion	19/12	AQ
Voyageur Pharmaceuticals Initiates International Expansion	14/12	AQ
Voyageur Pharmaceuticals "sees a gap in the market" for domestically-produced barium	28/23/28	AQ
Voyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast Media	14/23/14	AQ
Voyageur Pharmaceuticals Ltd. Announces Filing of Interim Financial Statements, Director Changes and Grant of Stock Options	01/23/01	AQ
Voyageur Pharmaceuticals Ltd. Announces DSU Grants	14/23/14	AQ
Voyageur Pharmaceuticals Publishes White Paper, SmoothX: A Promising New Positive Oral Contrast Agent That Enhances Patient Satisfaction and Diagnostic Excellence in CT Imaging	12/23/12	AQ
Voyageur Pharmaceuticals shares successful environmental assessment for minerals subsidiary	08/23/08	AQ
Voyageur Pharmaceuticals with a "big market to go for"	07/23/07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Voyageur Pharmaceuticals Ltd.

Equities

VM

CA92918C1014

Press Releases

Filters